Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of surfactant administration by MIST vs INSURE in neonatal respiratory distress syndrome
TCTR20210627001Phase 3Recruiting
- Sponsor
- Self
- Start
- Jun 2021
- Countries
- 1
01
Overview
A Phase 3 trial of bovactant in respiratory distress syndrome (RDS), sponsored by Self. Started Jun 2021; status: recruiting.
02
Drugs
bovactant
03
Conditions
respiratory distress syndrome (RDS)
Beyond the preview
Go deeper on TCTR20210627001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210627001.